The New Phase of the GLP-1 Journey When GLP-1 injections first gained attention, the focus was on weight loss
As much of a miracle weight-loss drug, as the media has made it out to be, it is intended to be used in adjunct to lifestyle interventions to be successful
They skip over the plateau at month four that made you question everything
Median overall survival was 67.9 months in the GLP-1 group, compared with 49 months in the group that did not receive a GLP-1 drug
Noom, Calibrate, and Embla say there is preliminary data to support their contention that many people can maintain weight loss through exercise and diet after stopping the medications (though some of the doctors Fortune spoke with were skeptical of those studies)
In the United States, obesity-attributable healthcare spending reaches USD 260 billion annually